The report "Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021" provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

http://www.marketsandmarkets.com/Market-Reports/clinical-trials-imaging-market-30446624.html

Early buyers will receive 10% customization on reports.

Major factors fueling market growth are the increasing number of contract research organizations, growth in the pharmaceutical and biotechnology industries, and increase in R&D spending are the key drivers for the growth of the clinical trial imaging market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=30446624

The clinical trial imaging market, on the basis of product and service, is segmented into service and software. Of these, the service segment is expected to account for the largest share as well as the highest CAGR of the clinical trial imaging market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

Geographically, the clinical trial imaging market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to command the largest share of the global clinical trial imaging market in 2016. This market is primarily driven by large R&D spending, growing number of pharmaceutical & biotechnology companies, and increasing number of CROs. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).